1. Estrogen Receptors Are Involved in the Neuroprotective Effect of Silibinin in Aβ1–42-Treated Rats
- Author
-
Weiwei Liu, Guo-Dong Yao, Yuko Ushiki-Kaku, Bo Liu, Shin-ichi Tashiro, Shunji Hattori, Takashi Ikejima, Lu Liu, Toshihiko Hayashi, Biao Zhou, Xiao-Yu Song, Lingyu Cui, and Mingyu Xia
- Subjects
0301 basic medicine ,chemistry.chemical_classification ,Amyloid ,business.industry ,Kinase ,Flavonoid ,Morris water navigation task ,Hippocampus ,Silibinin ,Estrogen receptor ,General Medicine ,Pharmacology ,Biochemistry ,Neuroprotection ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,chemistry.chemical_compound ,030104 developmental biology ,0302 clinical medicine ,chemistry ,Medicine ,business ,030217 neurology & neurosurgery - Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disease that is characterized by a cascade of pathologic changes. A widely discussed theory indicates that amyloid β (Aβ) peptides are the causative agents of AD. Silibinin, a flavonoid derived from milk thistle, is well known for its hepato-protective activities and we have reported the neuroprotective effects of silibinin. In this study, we investigated the role of estrogen receptors (ERs) in silibinin's neuroprotective effect on Aβ1-42-injected rats. Results of Morris water maze and novel object-recognition tests demonstrated that silibinin significantly attenuated Aβ1-42-induced memory impairment. Silibinin attenuated ERs and PI3K-Akt pathways, as well as modulated mitogen-activated protein kinases in the hippocampus of Aβ1-42-injected rats. Taken together, silibinin is a potential candidate in the treatment of Alzheimer's disease.
- Published
- 2018
- Full Text
- View/download PDF